The departure of CEO Jeffrey Immelt from General Electric Company (NYSE:GE) came as no surprise. Last month, we here at InvestorPlace suggested 10 CEOs likely to follow Ford Motor Company’s (NYSE:F) Mark Fields out the door — and Immelt was No. 1 on our list.
Source: ShutterstockInvestors cheered the move, as GE stock gained 3.6% on the news. One key reason: that 3.6% gain was roughly four years’ worth of returns on GE stock (including the GE dividend) under Immelt’s tenure.
Best High Tech Stocks To Buy Right Now: Avery Dennison Corporation(AVY)
Advisors' Opinion:- [By Ethan Ryder]
OMERS ADMINISTRATION Corp decreased its holdings in shares of Avery Dennison Corp (NYSE:AVY) by 9.7% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 69,500 shares of the industrial products company’s stock after selling 7,500 shares during the period. OMERS ADMINISTRATION Corp owned approximately 0.08% of Avery Dennison worth $7,096,000 as of its most recent SEC filing.
- [By Ethan Ryder]
Get a free copy of the Zacks research report on Avery Dennison (AVY)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Logan Wallace]
Oppenheimer Asset Management Inc. decreased its position in Avery Dennison Corp (NYSE:AVY) by 9.8% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 11,671 shares of the industrial products company’s stock after selling 1,265 shares during the period. Oppenheimer Asset Management Inc.’s holdings in Avery Dennison were worth $1,240,000 at the end of the most recent quarter.
- [By Stephan Byrd]
Strategy Asset Managers LLC acquired a new stake in Avery Dennison (NYSE:AVY) during the first quarter, HoldingsChannel.com reports. The firm acquired 23,500 shares of the industrial products company’s stock, valued at approximately $2,497,000.
Best High Tech Stocks To Buy Right Now: Cellect Biotechnology Ltd. (APOP)
Advisors' Opinion:- [By Max Byerly]
Get a free copy of the Zacks research report on CELLECT BIOTECH/S (APOP)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Stephan Byrd]
Media stories about CELLECT BIOTECH/S (NASDAQ:APOP) have been trending somewhat positive recently, according to Accern. The research firm ranks the sentiment of news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. CELLECT BIOTECH/S earned a daily sentiment score of 0.18 on Accern’s scale. Accern also assigned news headlines about the company an impact score of 46.3583768207142 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.
- [By Shane Hupp]
Cellect Biotechnology (NASDAQ: APOP) is one of 105 public companies in the “Surgical & medical instruments” industry, but how does it weigh in compared to its competitors? We will compare Cellect Biotechnology to related companies based on the strength of its valuation, profitability, dividends, analyst recommendations, risk, earnings and institutional ownership.
- [By Lisa Levin] Gainers Pacific Biosciences of California, Inc. (NASDAQ: PACB) rose 11.4 percent to $2.93 in pre-market trading. Check-Cap Ltd. (NASDAQ: CHEK) shares rose 6.3 percent to $4.76 in pre-market trading as the company announced the publication of CE Mark multicenter clinical study results on C-Scan® in Gut. Acacia Communications, Inc. (NASDAQ: ACIA) rose 6 percent to $ 35.20 in pre-market trading. Cellect Biotechnology Ltd. (NASDAQ: APOP) rose 6 percent to $7.60 in pre-market trading. Hexindai Inc. (NASDAQ: HX) rose 5.7 percent to $12.70 in pre-market trading. MoSys, Inc. (NASDAQ: MOSY) shares rose 5.3 percent to $2.07 in pre-market trading. Micron Technology, Inc. (NASDAQ: MU) rose 5 percent to $58.20 in pre-market trading after reporting a $10 billion buyback plan. Golden Ocean Group Limited (NASDAQ: GOGL) rose 4.1 percent to $8.63 in pre-market trading. MorphoSys AG (NASDAQ: MOR) rose 3.5 percent to $26.99 in pre-market trading. Cyren Ltd (NASDAQ: CYRN) shares rose 3.4 percent to $2.90 in pre-market trading. after reporting Q1 results. Box, Inc. (NYSE: BOX) rose 3.4 percent to $28.76 in pre-market trading. Kohl's Corporation (NYSE: KSS) shares rose 3.3 percent to $67.60 in the pre-market trading session after the company reported upbeat quarterly earnings. Micro Focus International plc (NYSE: MFGP) shares rose 3.1 percent to $18.40 in pre-market trading.
- [By Max Byerly]
Get a free copy of the Zacks research report on CELLECT BIOTECH/S (APOP)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Best High Tech Stocks To Buy Right Now: Gladstone Capital Corporation(GLAD)
Advisors' Opinion:- [By Motley Fool Transcribers]
Gladstone Capital Corp (NASDAQ:GLAD)Q1 2019 Earnings Conference CallFeb. 07, 2019, 8:30 a.m. ET
Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:Operator
- [By Ethan Ryder]
Get a free copy of the Zacks research report on Gladstone Capital (GLAD)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Ethan Ryder]
Van ECK Associates Corp lifted its position in shares of Gladstone Capital Co. (NASDAQ:GLAD) by 2.7% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 202,100 shares of the investment management company’s stock after buying an additional 5,304 shares during the period. Van ECK Associates Corp owned about 0.73% of Gladstone Capital worth $1,819,000 as of its most recent SEC filing.
- [By Taylor Cox]
Investor Events
Gladstone Capital Corporation (NASDAQ: GLAD) and Gladstone Investment Corporation (NASDAQ: GAIN) each holding an analyst/investor day Micron Technology, Inc (NASDAQ: MU) holding analyst/investor day Baxter International Inc (NYSE: BAX) investor conferenceTuesday
Notable Earnings - [By Logan Wallace]
Get a free copy of the Zacks research report on Gladstone Capital (GLAD)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Best High Tech Stocks To Buy Right Now: Hanwha Q CELLS Co., Ltd. (HQCL)
Advisors' Opinion:- [By Motley Fool Transcribers]
Hanwha Q CELLS Co., Ltd. (NASDAQ:HQCL)Q2 2018 Earnings Conference CallAug. 13, 2018, 8:00 a.m. ET
Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:Operator
- [By Lisa Levin] Companies Reporting Before The Bell Hanwha Q CELLS Co., Ltd. (NASDAQ: HQCL) is estimated to report quarterly earnings at $0.14 per share on revenue of $438.40 million. Remark Holdings, Inc. (NASDAQ: MARK) is projected to report quarterly loss at $0.35 per share on revenue of $19.45 million. Athenex, Inc. (NYSE: ATNX) is expected to report quarterly loss at $0.07 per share on revenue of $35.14 million. Mazor Robotics Ltd. (NASDAQ: MZOR) is estimated to report quarterly loss at $0.08 per share on revenue of $15.14 million. Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) is projected to report a quarterly loss at $0.14 per share. SuperCom Ltd. (NASDAQ: SPCB) is expected to report quarterly earnings at $0.08 per share on revenue of $9.50 million. Lonestar Resources US Inc. (NASDAQ: LONE) is projected to report quarterly loss at $0.04 per share on revenue of $30.68 million. Nine Energy Service, Inc. (NASDAQ: NINE) is estimated to report quarterly earnings at $0.1 per share on revenue of $165.76 million. VEON Ltd. (NASDAQ: VEON) is projected to report quarterly earnings at $0.05 per share on revenue of $212.00 million.
- [By Travis Hoium]
The impact will have ripple effects across the industry. Major manufacturers like Canadian Solar (NASDAQ:CSIQ), JinkoSolar (NYSE:JKS), Hanwha Q Cells (NASDAQ:HQCL), and JA Solar (NASDAQ:JASO) will see margins squeezed as volume and sales prices fall. They were all enjoying higher margins and strong demand in early 2018, so the could reverse to net losses later this year.
- [By Lisa Levin]
Some of the stocks that may grab investor focus today are:
Wall Street expects Agilent Technologies, Inc. (NYSE: A) to post quarterly earnings at $0.64 per share on revenue of $1.21 billion after the closing bell. Agilent shares rose 0.86 percent to close at $69.45 on Friday. Analysts expect Hanwha Q CELLS Co., Ltd. (NASDAQ: HQCL) to report quarterly earnings at $0.14 per share on revenue of $438.40 million before the opening bell. Hanwha Q CELLS shares fell 0.29 percent to close at $6.92 on Friday. NiSource Inc. (NYSE: NI) disclosed a 24.96 million share common stock offering via selling holders. NiSource shares rose 0.08 percent to close at $24.93 on Friday. Analysts are expecting Vipshop Holdings Limited (NYSE: VIPS) to have earned $0.18 per share on revenue of $3.10 billion in the latest quarter. Vipshop will release earnings after the markets close. Vipshop shares rose 0.20 percent to $15.14 in after-hours trading.Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
- [By Stephan Byrd]
Ambarella (NASDAQ:AMBA) and Hanwha Q Cells (NASDAQ:HQCL) are both small-cap computer and technology companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, earnings, risk, dividends, valuation, analyst recommendations and profitability.
- [By Rich Smith]
Shares of Hanwha Q Cells Co (NASDAQ:HQCL) are down more than 4% so far this year -- and that's the good news. Canadian Solar is off 20% while JinkoSolar Holding is down a whopping 43%. The cost of Chinese solar modules, which make up one-third the cost of a deployed solar power system, are expected to decline 35% this year, then fall another 10% to 15% next year, according to Bloomberg.
Best High Tech Stocks To Buy Right Now: West Pharmaceutical Services, Inc.(WST)
Advisors' Opinion:- [By Stephan Byrd]
Get a free copy of the Zacks research report on West Pharmaceutical Services (WST)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Lee Jackson]
West Pharmaceutical Services
This below the radar company could offer a big upside for shareholders this year. West Pharmaceutical Services Inc. (NYSE: WST) is a leading manufacturer of components used for injectable drug delivery systems, including rubber stoppers and syringe plungers, and also offers contract manufacturing services to the healthcare and consumer products industry. - [By Ethan Ryder]
West Pharmaceutical Services (NYSE: WST) and Carlisle Companies (NYSE:CSL) are both mid-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, profitability, risk, dividends, earnings and institutional ownership.
- [By Logan Wallace]
Get a free copy of the Zacks research report on West Pharmaceutical Services (WST)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
No comments:
Post a Comment